Computational comparison of common event-based differential splicing tools: practical considerations for laboratory researchers
暂无分享,去创建一个
Steven van Dijk | Peter Kampstra | Gerrit Jansen | Ittai B. Muller | Stijn Meijers | Michel van Elswijk | Marry Lin | Anna M. Wojtuszkiewicz | Robert de Jonge | Jacqueline Cloos | G. Jansen | J. Cloos | A. Wojtuszkiewicz | I. Muller | Marry Lin | R. D. Jonge | P. Kampstra | S. V. Dijk | Stijn Meijers | R. de Jonge | Steven van Dijk | Michel van Elswijk
[1] Yan Wang,et al. Mechanism of alternative splicing and its regulation. , 2015, Biomedical reports.
[2] Y. Assaraf,et al. Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance , 2015, Expert opinion on drug metabolism & toxicology.
[3] J. Bertino,et al. Enzymatic synthesis of folylpolyglutamates. Characterization of the reaction and its products. , 1980, The Journal of biological chemistry.
[4] S. Salzberg,et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.
[5] G. Peters,et al. The association of aberrant folylpolyglutamate synthetase splicing with ex vivo methotrexate resistance and clinical outcome in childhood acute lymphoblastic leukemia , 2016, Haematologica.
[6] N. Lee,et al. Aberrant RNA Splicing in Cancer and Drug Resistance , 2018, Cancers.
[7] Y. Assaraf,et al. Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia. , 2009, Blood.
[8] Lan Lin,et al. rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data , 2014, Proceedings of the National Academy of Sciences.
[9] B. Prabhakar,et al. Alternative splicing as a biomarker and potential target for drug discovery , 2015, Acta Pharmacologica Sinica.
[10] G. Peters,et al. Methotrexate resistance in relation to treatment outcome in childhood acute lymphoblastic leukemia , 2015, Journal of Hematology & Oncology.
[11] Eric T. Wang,et al. Alternative Isoform Regulation in Human Tissue Transcriptomes , 2008, Nature.
[12] B. Shane,et al. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure. , 1995, Oncology research.
[13] Björn Usadel,et al. Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..
[14] B. Frey,et al. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing , 2008, Nature Genetics.
[15] E. Giovannetti,et al. Glucocorticoid Resistant Pediatric Acute Lymphoblastic Leukemia Samples Display Altered Splicing Profile and Vulnerability to Spliceosome Modulation , 2020, Cancers.
[16] Arfa Mehmood,et al. Systematic evaluation of differential splicing tools for RNA-seq studies , 2019, Briefings Bioinform..
[17] E. Wang,et al. Analysis and design of RNA sequencing experiments for identifying isoform regulation , 2010, Nature Methods.
[18] E. Giovannetti,et al. Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models. , 2016, Journal of visualized experiments : JoVE.
[19] Miha Skalic,et al. SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions , 2016, Genome Biology.
[20] Gael P. Alamancos,et al. Methods to study splicing from high-throughput RNA sequencing data. , 2013, Methods in molecular biology.
[21] Lior Pachter,et al. Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.
[22] F. Baralle,et al. Alternative splicing as a regulator of development and tissue identity , 2017, Nature Reviews Molecular Cell Biology.
[23] D. Baralle,et al. RNA splicing in human disease and in the clinic. , 2017, Clinical science.
[24] Yanmei Xu,et al. Mechanism of alternative splicing and its regulation (Review) , 2015 .
[25] G. Peters,et al. Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance , 2016, International journal of cancer.
[26] E. Giovannetti,et al. Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma , 2018, EBioMedicine.
[27] R. Guigó,et al. Modelling and simulating generic RNA-Seq experiments with the flux simulator , 2012, Nucleic acids research.
[28] J. Bertino,et al. Decreased folylpolyglutamate synthetase activity as a mechanism of methotrexate resistance in CCRF-CEM human leukemia sublines. , 1991, The Journal of biological chemistry.
[29] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[30] Julie A. Dickerson,et al. Comparisons of computational methods for differential alternative splicing detection using RNA-seq in plant systems , 2014, BMC Bioinformatics.
[31] Donny D. Licatalosi,et al. RNA processing and its regulation: global insights into biological networks , 2010, Nature Reviews Genetics.
[32] W. Lems,et al. Association of altered folylpolyglutamate synthetase pre-mRNA splicing with methotrexate unresponsiveness in early rheumatoid arthritis , 2020, Rheumatology.
[33] Rob Patro,et al. Salmon provides fast and bias-aware quantification of transcript expression , 2017, Nature Methods.
[34] D. Rio,et al. Mechanisms and Regulation of Alternative Pre-mRNA Splicing. , 2015, Annual review of biochemistry.